Neurogene (NGNE) Share-based Compensation (2013 - 2026)

Neurogene (NGNE) has 14 years of Share-based Compensation data on file, last reported at $3.6 million in Q1 2026.

• Quarterly Share-based Compensation fell 10.35% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$419000.0 (down 110.35% YoY) and the FY2024 annual result came in at $60000.0, down 95.77% from the prior year.
• Share-based Compensation rose to $3.6 million in Q1 2026, from -$4.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.8 million in Q3 2024 to a low of -$5.8 million in Q4 2024.
• A 5-year average of $454214.3 and a median of $709000.0 in 2023 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2024 — Share-based Compensation sank 1726.2% — and 2025, when it soared 6646.67%.
• Tracing NGNE's Share-based Compensation over 5 years: stood at -$5.5 million in 2022, then surged by 106.41% to $355000.0 in 2023, then slumped by 1726.2% to -$5.8 million in 2024, then grew by 29.88% to -$4.0 million in 2025, then jumped by 189.65% to $3.6 million in 2026.
• The last three Share-based Compensation figures came in at $3.6 million (Q1 2026), -$4.0 million (Q2 2025), and $4.0 million (Q1 2025), per Business Quant data.